GRHL3 and metabolic dysfunction-associated steatohepatitis: The decreased protein levels of Grhl3 correlated well with the decreased NOS3 phosphorylation in those time points (Fig. 2E and F), signifying the importance of miR21-induced Grhl3 suppression being crucial for NO bioavailability in NASH.